BDBM50535081 CHEMBL4436576

SMILES Cc1ccc(cc1)-c1cc2nccnc2c(NCCCCN)n1

InChI Key InChIKey=FYJFZOONLWHKMF-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50535081   

TargetTyrosine-protein kinase JAK1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of JAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase SYK(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of SYK in human B cells assessed as suppression of anti-IgM-induced CD69 surface expression preincubated for 30 mins followed by anti-IgM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetAurora kinase A(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of Aurora A (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of LRRK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase SYK(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of SYK in human Ramos cells assessed as suppression of anti-IgM induced Erk1/2 phosphorylation preincubated for 30 mins followed by anti-I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.59E+3nMAssay Description:Inhibition of KDR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluoresce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase SYK(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50535081(CHEMBL4436576)
Affinity DataIC50: 251nMAssay Description:Inhibition of N-terminal 6His-tagged full length human recombinant SYK expressed in baculovirus using Biotin-AAAEEIYGEI as substrate after 60 mins by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed